Features of the novel coronavirus infection in cancer patients
A novel coronavirus (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is largely associated with various coagulopathies, which can lead to either bleeding and thrombocytopenia or hypercoagulation and thrombosis. Thrombohemorrhagic complications also could accompany the development of cancer p...
Saved in:
Main Authors: | A. D. Makatsariya (Author), I. Elalamy (Author), B. Brenner (Author), A. V. Vorobev (Author), L. A. Ashrafyan (Author), E. V. Maslenkova (Author), V. O. Bitsadze (Author), J. Kh. Khizroeva (Author), A. S. Shkoda (Author), A. G. Solopova (Author), V. N. Galkin (Author), J.-C. Gris (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel coronavirus infection (COVID-19) and risk groups in obstetrics and gynecology
by: A. D. Makatsariya, et al.
Published: (2020) -
Features of nervous system damage in antiphospholipid syndrome
by: O. N. Voskresenskaya, et al.
Published: (2021) -
Platelets, thrombo-inflammation and cancer
by: E. V. Slukhanchuk, et al.
Published: (2022) -
Antiphospholipid antibodies as a potential factor of tumor progression
by: Z. D. Aslanova, et al.
Published: (2024) -
Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms
by: E. V. Slukhanchuk, et al.
Published: (2022)